入排依据:The record is from a Phase III randomized controlled trial in human oncology, but the provided abstract is empty and no keywords or MeSH terms explicitly signal the presence of survival, progression, recurrence, death, hazard, or other time-to-event efficacy outcomes. Without abstract content or other data confirming such outcomes, eligibility cannot be determined.
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板